Zoetis Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares fell 2.70% to $73.79 on Friday, underperforming the broader market and some competitors like Merck & Co., though they outperformed IDEXX Laboratories. The stock closed 54.02% below its 52-week high of $160.48. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) slipped 2.70% to $73.79 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.17% to 7,785.76 and Dow Jones Industrial Average falling 0.20% to 53,732.41.
Zoetis Inc. closed 54.02% below its 52-week high of $160.48, which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Merck & Co. Inc. (MRK) rose 0.21% to $135.84 and IDEXX Laboratories Inc. (IDXX) fell 2.82% to $550.96.
Trading volume (4.4 M) remained 2.5 million below its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-14-26 1659ET